Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University’s LIFE project has launched a new set of app-based training scenarios that help healthcare workers in Africa safely manage and treat cases of children with suspected COVID-19

Nurse wearing a face mask

Life-saving Instruction for Emergencies (LIFE) is a smartphone-based virtual learning platform that allows healthcare workers to access high quality medical training in low-resource settings. Developed by doctors, nurses and researchers at the KEMRI-Wellcome Trust Research Programme (KWTRP) in Kenya and the University of Oxford, the platform has now launched new training scenarios to help healthcare workers in Africa safely deliver care to children with suspected COVID-19.

LIFE allows healthcare workers to enter a realistic 3D virtual hospital on their own smartphones, allowing them to train anywhere, anytime. In low-resource settings such as Kenya, access to simulation training can be difficult and expensive, so using their own smartphones to train could enable more healthcare workers to receive the high-quality training they need to save lives.

Neonatal resuscitation training delivered through the LIFE smartphone app has been rolled out to more than 5,000 healthcare workers through partnerships with medical and nursing schools and professional organisations such as the Kenya Paediatric Association and the Nursing Council of Kenya. This new update to the LIFE app adds three new training scenarios on the management of children with suspected covid-19.

Conrad Wanyama, a nurse from the KEMRI-Wellcome Trust Research Programme who led the development of the covid-19 clinical content, said:

"We have used official WHO guidance to develop a highly engaging training app for healthcare workers in Africa. The covid-19 scenarios use 3D animations and videos to show how to follow correct infection control procedures to safely and effectively manage children who are suspected of having covid-19."

Dr Chris Paton, the lead researcher for LIFE from the University of Oxford, commented:

“Smartphones are now very commonly used by healthcare workers in Africa. After downloading the app for free to their phones, healthcare workers can now train anywhere that is convenient and learn the key steps they need to know to save lives in emergencies.”

Tuti Ng’ang’a, a DPhil student at the University of Oxford, studied the effect of LIFE on healthcare workers’ learning gains. He said:

“There is a considerable learning gain between the first two rounds of learning for healthcare workers that use the LIFE app. My research showed that new approaches to adaptive feedback linked to how healthcare workers spaced their learning could improve learning gains further.”

 

Life-saving Instruction for Emergences (LIFE) is a virtual reality and smartphone app delivering medical training through mobile and VR platforms. The platform was initially developed by clinicians and researchers at the KEMRI-Wellcome Trust Research Programme and the University of Oxford, and its development has been supported by HTC, Oxford University Innovation, GCRF, the Bill and Melinda Gates Foundation, the Wellcome Trust, Saving Lives at Birth and Médecins Sans Frontières.

LIFE is available to download for free for smartphones or search for “Life-saving Instruction for Emergencies” on the Google Play Store.

Follow the LIFE project on twitter @OxLIFEproject

Similar stories

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

@Oxford Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

UK National Health Service begins rollout of Oxford coronavirus vaccine

@Oxford General

The first patients are being vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, at the Oxford University NHS Hospitals Trust. The Oxford AstraZeneca vaccinations will be delivered at a small number of hospitals for the first few days for surveillance purposes, as is standard practice, before the bulk of supplies are sent to hundreds of GP-led services later in the week.

Receiving and responding to community feedback during health system crises in Kenya

KWTRP Publication Research

The responsiveness of a health system is one of its goals, alongside fairness in financing and outcomes. Listening and responding to the public can make a health system stronger and fairer. However, responsiveness is likely to be undermined, especially for vulnerable and marginal populations, in periods of crises such as disease outbreaks. In the current COVID-19 crisis, there has been more focus on health system control interventions, with minimal consideration of community views. KWTRP colleagues in Kenya consider community engagement and citizens feedback channels, concerns raised by the public and how they were handled, and highlight lessons learned.

Susie Dunachie awarded flagship NIHR career development award

@Oxford Awards & Appointments

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand. Congratulations!

RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

@Oxford Research

Established in March 2020, the RECOVERY trial tests a range of potential treatments for COVID-19, including azithromycin, a widely used antibiotic that also reduces inflammation. The azithromycin arm of the trial was established to determine whether or not the drug has a meaningful benefit among patients hospitalised with COVID-19. A preliminary analysis shows no significant difference in the primary endpoint of 28-day mortality; there was also no evidence of beneficial effects on the risk of progression to mechanical ventilation or length of hospital stay.

AfOx receives the Wellcome Institutional Strategic Support Fund to launch the Africa Health Innovation Platform

@Oxford

AfOx in collaboration with partners across the UK and Africa has received a Wellcome Institutional Strategic Support Fund to establish an Africa Health Innovation Platform. The multi-disciplinary platform will support African innovators who develop new solutions to Africa’s health challenges, bringing together researchers, entrepreneurs, investors, technologists, policymakers, and change leaders to develop new approaches towards prevention, early detection and treatment of diseases.